WallStreetZenWallStreetZen

NASDAQ: ASTH
Astrana Health Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ASTH past earnings growth

How has ASTH's earnings growth performed historically?
Company
30%
Industry
8.7%
Market
61.16%
ASTH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ASTH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ASTH's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ASTH past revenue growth

How has ASTH's revenue growth performed historically?
Company
21.19%
Industry
8.53%
Market
16.96%
ASTH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ASTH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ASTH's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ASTH earnings and revenue history

Current Revenue
$1.4B
Current Earnings
$60.7M
Current Profit Margin
4.4%

ASTH Return on Equity

Current Company
10.5%
Current Industry
-82.7%
Current Market
188%
ASTH's Return on Equity (10.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ASTH announces earnings.

ASTH Return on Assets

Current Company
6%
Current Industry
5.7%
ASTH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ASTH Return on Capital Employed

Current Company
15.22%
Current Industry
11.9%
ASTH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ASTH vs Medical Care Facility Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ASTH$1.39B$133.74M$60.72M+21.68%+31.55%
AMN$3.79B$500.98M$210.68M+12.15%+12.47%
AGL$4.32B-$234.99M-$262.60M+55.50%N/A
LFST$1.06B-$64.94M-$186.26M+49.29%N/A
USPH$604.80M$65.39M$28.24M+5.91%-0.46%
View Top Medical Care Facility Stocks

ASTH earnings dates

Next earnings date
May 6, 2024

Astrana Health Earnings & Revenue FAQ

What were ASTH's earnings last quarter?

On Invalid Date, Astrana Health (NASDAQ: ASTH) reported Q4 2023 earnings per share (EPS) of $0.26, up 388.89% year over year. Total Astrana Health earnings for the quarter were $12.36 million. In the same quarter last year, Astrana Health's earnings per share (EPS) was -$0.09.

If you're new to stock investing, here's how to buy Astrana Health stock.

What was ASTH's earnings growth in the past year?

As of Q2 2024, Astrana Health's earnings has grown 30% year over year. This is 21.3 percentage points higher than the US Medical Care Facilities industry earnings growth rate of 8.7%. Astrana Health's earnings in the past year totalled $60.72 million.

What is ASTH's earnings date?

Astrana Health's earnings date is Invalid Date. Add ASTH to your watchlist to be reminded of ASTH's next earnings announcement.

What was ASTH's revenue last quarter?

On Invalid Date, Astrana Health (NASDAQ: ASTH) reported Q4 2023 revenue of $353.04 million up 20% year over year. In the same quarter last year, Astrana Health's revenue was $294.21 million.

What was ASTH's revenue growth in the past year?

As of Q2 2024, Astrana Health's revenue has grown 21.19% year over year. This is 12.67 percentage points higher than the US Medical Care Facilities industry revenue growth rate of 8.53%. Astrana Health's revenue in the past year totalled $1.39 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.